Cardio Diagnostics Inc.

0.34
-0.02 (-5.56%)
At close: Apr 02, 2025, 3:59 PM
0.37
8.06%
After-hours: Apr 02, 2025, 07:59 PM EDT

Company Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test.

Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Cardio Diagnostics Inc.
Cardio Diagnostics  Inc. logo
Country United States
IPO Date Jan 14, 2022
Industry Biotechnology
Sector Healthcare
Employees 13
CEO Dr. Meeshanthini V. Dogan Ph.D.

Contact Details

Address:
400 N Aberdeen St
Chicago, Illinois
United States
Website https://cardiodiagnosticsinc.com

Stock Details

Ticker Symbol CDIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001870144
CUSIP Number 14159C103
ISIN Number US14159C1036
Employer ID 87-0925574
SIC Code 2835

Key Executives

Name Position
Dr. Meeshanthini V. Dogan Ph.D. Co-Founder, Chief Executive Officer & Director
Elisa Michael Luqman Esq., J.D., M.B.A. Chief Financial Officer & Principal Accounting Officer
Timur Dogan Ph.D. Chief Technology Officer
Dr. Robert A. Philibert M.D., Ph.D. Co-Founder, Chief Medical Officer & Director
Khullani Abdullahi J.D. Vice President of Revenue & Strategy

Latest SEC Filings

Date Type Title
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Apr 01, 2025 4 Filing
Mar 25, 2025 424B3 Filing
Mar 25, 2025 424B3 Filing
Mar 20, 2025 10-K Annual Report
Mar 13, 2025 3 Filing
Feb 21, 2025 8-K Current Report
Feb 14, 2025 424B5 Filing